EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY 4.0

LC-MS/MS method for quantification of avacopan in human plasma from patients treated for antineutrophil cytoplasmic antibody-associated vasculitis

Juliette Blondel, Léo Froelicher-Bournaud, Stanislas Faguer, Jean Philippe Coindre, Benjamin Terrier, Michel Vidal, Xavier Declèves, Alicja Puszkiel, Benoit Blanchet

Journal of Pharmaceutical and Biomedical Analysis · 2026

DOI: 10.1016/j.jpba.2025.117151 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Journal of Pharmaceutical and Biomedical Analysis, 2026. Verfasst von Juliette Blondel und 8 weiteren Autor:innen. Beteiligte Einrichtung: Service de Biologie du Médicament et Toxicologie, CARPEM, Hôpital Cochin, AP-HP, Paris, France. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Avacopan is a new treatment for antineutrophil cytoplasmic antibody-associated vasculitis (ANCA-AAV). To date, there has been a lack of published bioanalytical methods to assay it in plasma, resulting in sparse pharmacokinetic data in clinical settings. The objective of this study was to develop and validate a liquid chromatography tandem mass spectrometry (LC-MS/MS) method for the quantification of avacopan in human plasma. [2H4]-Avacopan was as used as internal standard (IS). Samples were prepared by protein precipitation and separated was on an Accurore® C18 column (2.1 ×50 mm, 2.6 µm), with an elution gradient at a flow rate of 0.5 mL/min. The mobile phase consisted of acetonitrile (0.1 % formic acid) and water (0.1 % formic acid). The analysis run time was 6 min. Avacopan was detected by electrospray ionization on a TSQ Quantis® triple quadrupole mass spectrometer (ThermoFisher Scientific). The linearity of method ranged from 10 to 800 ng/mL. The within-run and between-run relative standard deviations were < 10.2 %. The within-run and between-run relative errors ranged from 2.4 % to 14.4 %. The IS-normalized matrix effect ranged from 2.2 % to 5.1 %, and the IS-normalized extraction recovery ranged from 104.3 % to 109.7 %. The method was fully validated, including checks on linearity, dilution integrity and carry-over. Plasma samples from 16 patients undergoing treatment for ANCA-AAV were then successfully treated with the method. The reanalysis of the samples incurred was below 14 %. This method is suitable for plasma drug monitoring of avacopan because it is both accurate and precise, and meets all validation criteria.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tandem Mass SpectrometryAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisHumansReproducibility of ResultsChromatography, LiquidDrug MonitoringSpectrometry, Mass, Electrospray IonizationLimit of DetectionLiquid Chromatography-Mass Spectrometry

Stichwörter der Autor:innen

AvacopanLC-MS/MSPharmacokineticsTherapeutic drug monitoringVasculitis

Autor:innen und Institutionen

  • Service de Biologie du Médicament et Toxicologie, CARPEM, Hôpital Cochin, AP-HP, Paris, France.
  • Université Paris Cité, Inserm, Pharmacologie et évaluations des thérapeutiques chez l'enfant et la femme enceinte, Paris 75006, France; Service de pharmacologie périnatale, Pédiatrique et adulte, AP-HP, Hôpital Cochin,…
  • Département de Néphrologie et transplantation d'organes, Centre de Référence des Maladies Rénales Rares - SORARE, CHU de Toulouse, Toulouse, France.
  • Service d'Immunologie clinique, Centre hospitalier du Mans, Le Mans, France.
  • Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune and Autoinflammatory Diseases of Ile de France, East and West, Cochin Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France…
  • Service de Biologie du Médicament et Toxicologie, CARPEM, Hôpital Cochin, AP-HP, Paris, France; Université Paris Cité, CNRS, INSERM, CiTCoM, Paris, France.

Zitieren

APA

Blondel, J., Froelicher-Bournaud, L., Faguer, S., Coindre, J. P., Terrier, B., Vidal, M., Declèves, X., Puszkiel, A., & Blanchet, B. (2026). LC-MS/MS method for quantification of avacopan in human plasma from patients treated for antineutrophil cytoplasmic antibody-associated vasculitis. Journal of Pharmaceutical and Biomedical Analysis. https://doi.org/10.1016/j.jpba.2025.117151

Vancouver

Blondel J, Froelicher-Bournaud L, Faguer S, Coindre JP, Terrier B, Vidal M, et al. LC-MS/MS method for quantification of avacopan in human plasma from patients treated for antineutrophil cytoplasmic antibody-associated vasculitis. Journal of Pharmaceutical and Biomedical Analysis. 2026. doi:10.1016/j.jpba.2025.117151

BibTeX
@article{Blondel2026,
  author = {Blondel, Juliette and Froelicher-Bournaud, Léo and Faguer, Stanislas and Coindre, Jean Philippe and Terrier, Benjamin and Vidal, Michel and Declèves, Xavier and Puszkiel, Alicja and Blanchet, Benoit},
  title = {LC-MS/MS method for quantification of avacopan in human plasma from patients treated for antineutrophil cytoplasmic antibody-associated vasculitis},
  journal = {Journal of Pharmaceutical and Biomedical Analysis},
  year = {2026},
  doi = {10.1016/j.jpba.2025.117151}
}
Kostenlos starten →